Loading…

Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy

Left ventricular hypertrophy (LVH) is a common complication in patients with CKD and an independent risk factor for death. Changes in the levels of uremic solutes or Klotho have been reported to be related to CKD, whereas the relationships between these factors and CKD-associated LVH remain unclear....

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2015-10, Vol.26 (10), p.2434-2446
Main Authors: Yang, Ke, Wang, Cheng, Nie, Ling, Zhao, Xiaohui, Gu, Jun, Guan, Xu, Wang, Song, Xiao, Tangli, Xu, Xinli, He, Ting, Xia, Xuefeng, Wang, Junping, Zhao, Jinghong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Left ventricular hypertrophy (LVH) is a common complication in patients with CKD and an independent risk factor for death. Changes in the levels of uremic solutes or Klotho have been reported to be related to CKD, whereas the relationships between these factors and CKD-associated LVH remain unclear. Here, we investigated the interaction between Klotho and indoxyl sulfate (IS), a typical uremic solute, in CKD-associated LVH. In a survey of 86 patients with CKD, a negative relationship was found between serum levels of IS and Klotho (r=-0.59, P
ISSN:1046-6673
1533-3450
DOI:10.1681/ASN.2014060543